XML 32 R10.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:      
Net income $ 436,066 $ 465,284 $ 150,566
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of intangible assets 641,244 807,925 657,351
Share-based compensation expense 104,840 140,079 130,302
Pension expense 14,593 13,881 9,207
Amortization of debt discount and issuance costs 21,977 25,257 16,753
Write-off of right of use assets 8,805 20,056 9,626
Loss on extinguishment of debt 0 56,393 8,152
Gain (adjustments to gain) on AMC Divestiture 4,175 (429,102) 0
Loss on sale and write down of property and equipment, net 3,178 3,710 2,331
Deferred taxes (138,616) (142,271) (149,560)
Share in net (income) loss of equity investees (230) 18,194 23,077
Changes in derivative instruments 44,286 (3,116) 128,841
Changes in operating assets and liabilities:      
Accounts receivable 80,097 108,562 168,604
Contract assets (135,911) (95,403) (73,539)
Prepaid expenses and other current assets 42,486 (28,395) (23,035)
Income taxes (246,681) 112,097 14,948
Accounts payable and accrued liabilities (23,012) (65,887) (127,092)
Deferred revenue 3,565 (42,974) (128,395)
Other assets (15,264) 24,849 (11,297)
Operating lease assets and liabilities, net (14,980) (21,448) (27,635)
Net cash provided by operating activities 830,618 967,691 779,205
Cash flows from investing activities:      
Additions of property and equipment (143,222) (159,295) (123,832)
Purchase of Micro Focus, net of cash acquired 0 (9,272) (5,657,963)
Proceeds (adjustments to proceeds) from AMC Divestiture (11,686) 2,229,187 0
Settlement of derivative instruments (10,380) 0 0
Realized gain on financial instruments 0 0 131,248
Proceeds from interest on derivative instruments 5,166 4,456 0
Other investing activities 6,614 (9,759) (873)
Net cash provided by (used in) investing activities (153,508) 2,055,317 (5,651,420)
Cash flows from financing activities:      
Proceeds from issuance of Common Shares from exercise of stock options and ESPP 35,372 66,914 39,331
Proceeds from long-term debt and Revolver 0 0 4,927,450
Repayment of long-term debt and Revolver (35,851) (2,568,352) (202,926)
Debt issuance costs (1,066) (3,833) (77,899)
Net change in transition services agreement obligation (15,278) 15,278 0
Repurchase of Common Shares (413,256) (150,017) 0
Purchase of treasury stock (130,649) (53,085) (21,919)
Payments of dividends to shareholders (271,523) (267,362) (259,549)
Other financing activities (2,428) (1,447) (1,435)
Net cash provided by (used in) financing activities (834,679) (2,961,904) 4,403,053
Foreign exchange gain (loss) on cash held in foreign currencies 32,882 (12,263) 7,203
Increase (decrease) in cash, cash equivalents and restricted cash during the year (124,687) 48,841 (461,959)
Cash, cash equivalents and restricted cash at beginning of the year 1,282,793 1,233,952 1,695,911
Cash, cash equivalents and restricted cash at end of the year 1,158,106 1,282,793 1,233,952
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 1,156,496 1,280,662 1,231,625
Restricted cash [1] 1,610 2,131 2,327
Total cash, cash equivalents and restricted cash $ 1,158,106 $ 1,282,793 $ 1,233,952
[1] Restricted cash is classified under the Prepaid expenses and other current assets and Other assets line items on the Consolidated Balance Sheets (Note 9).